These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32716150)

  • 1. EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis.
    Wang M; Liu T; Hu X; Yin A; Liu J; Wang X
    Panminerva Med; 2020 Sep; 62(3):150-154. PubMed ID: 32716150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
    Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
    Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ100284 promotes invasion and migration of osteosarcoma cells by down-regulating PTEN and EMP1.
    Liu YD; Liu LP
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6540-6550. PubMed ID: 32633341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2.
    Cheng ZH; Luo C; Guo ZL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9267-9276. PubMed ID: 31773678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3β promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase.
    Mai W; Kong L; Yu H; Bao J; Song C; Qu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33969873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner.
    Liu T; Zhou W; Cai B; Chu J; Shi G; Teng H; Xu J; Xiao J; Wang Y
    Mol Med Rep; 2015 Sep; 12(3):4346-4351. PubMed ID: 26062523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEX3C promotes osteosarcoma malignant progression through negatively regulating FGF14.
    Cao Y; Jiang F; Zhang S; Yang L; Sun Y
    J BUON; 2020; 25(3):1554-1561. PubMed ID: 32862604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRX1 hypomethylation in osteosarcoma metastasis.
    Lu J; Wang J
    Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
    Han Y; Zhao X; Sun Y; Sui Y; Liu J
    J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
    Dai J; Lu L; Kang L; Zhang J
    Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
    Shen A; Zhang Y; Yang H; Xu R; Huang G
    J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
    Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
    Sun G; Zhao G; Lu Y; Wang Y; Yang C
    Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
    Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
    Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Nucleotide Polymorphism (rs1056629) in 3'-UTR of MMP-9 is Responsible for a Decreased Risk of Metastatic Osteosarcoma by Compromising its Interaction with microRNA-491-5p.
    Tian X; Zhang X
    Cell Physiol Biochem; 2016; 38(4):1415-24. PubMed ID: 27023472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
    Huang JF; Du WX; Chen JJ
    J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.